Dysregulation of SELENOI Is Associated with TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
Cells · 2025
DOI: 10.3390/cells14181457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Finula I Isik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, FightMND.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by progressive degeneration of motor neurons and accumulation of TAR DNA-binding protein 43 (TDP-43) in the brain. Increasing evidence indicates that aberration in lipid synthesis or regulation underlies neuronal dysfunction and degeneration. Phosphatidylethanolmine (PE) is an abundant phospholipid in the brain and is synthesized by the SELENOI gene. SELENOI is important in motor neuron development and function, as demonstrated in hereditary spastic paraplegia, a neurological disorder in which SELENOI is mutated. Despite this, virtually nothing was known about SELENOI in the context of ALS neuropathology. We therefore undertook a comprehensive assessment of PE in ALS brain tissues, using sophisticated liquid chromatography-mass spectrometry, and investigated how SELENOI regulates TDP-43 expression. PE levels were significantly decreased in the disease-affected motor cortex of ALS compared to controls and were inversely associated with disease duration. In contrast, PE levels were unaltered in the disease-unaffected cerebellum. Consistent with this, SELENOI expression was dysregulated only in the motor cortex of ALS. The correlation between SELENOI and TDP-43 was also lost in the motor cortex of ALS. A knockdown of SELENOI expression in neuronal cells caused an upregulation of TDP-43 expression. When put together, these results suggest that SELENOI dysregulation may contribute to TDP-43 pathology in ALS brain. Our study has provided new insights into an unrecognized pathway in ALS brain and revealed new targets for controlling TDP-43 pathology in ALS brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia.
- School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
- Bioanalytical Mass Spectrometry Facility, University of New South Wales, Sydney, NSW 2052, Australia.
- School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
ORCID-Profile: Finula I Isik, Jasmin Galper, Russell Pickford, Nicolas Dzamko, YuHong Fu, Woojin Scott Kim
Förderung
- NIAAA NIH HHS
- FightMND
Zitieren
APA
Isik, F. I., Galper, J., Pickford, R., Dzamko, N., Fu, Y., & Kim, W. S. (2025). Dysregulation of SELENOI Is Associated with TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. Cells. https://doi.org/10.3390/cells14181457
Vancouver
Isik FI, Galper J, Pickford R, Dzamko N, Fu Y, Kim WS. Dysregulation of SELENOI Is Associated with TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. Cells. 2025. doi:10.3390/cells14181457
BibTeX
@article{Isik2025,
author = {Isik, Finula I and Galper, Jasmin and Pickford, Russell and Dzamko, Nicolas and Fu, YuHong and Kim, Woojin Scott},
title = {Dysregulation of SELENOI Is Associated with TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14181457}
}
EUVIMED